Why Aprea Therapeutics Shares Hit A New 52-Week Low Today

Aprea Therapeutics Inc APRE shares are trading lower by 17.59% to $5.20 after the company announced pricing of a $5.5 million underwritten public offering of common stock.

What Else?

The pricing of the company's previously announced underwritten public offering of 1,050,000 shares of its common stock will be at a public offering price of $5.25 per share.

See Also: Forget Lucid Overtaking Tesla, Analyst Says EV Maker May Instead Be Headed For Titanic's Fate

In addition, Aprea says the company has granted the underwriter a 30-day option to purchase up to an additional 157,500 shares of common stock.

Aprea says the net proceeds received from the public offering will enable the company to continue developing its clinical asset, ATRN-119, its pre-clinical asset ATRN-W1051 and for general corporate purposes.

According to data from Benzinga Pro, APRE has a 52-week high of $40.80 and a 52-week low of $4.74.